MedPath

Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14

Not Applicable
Completed
Conditions
Opioid-Related Disorders
Substance-Related Disorders
Interventions
Drug: 30% Nitrous oxide
Other: Placebo
Drug: 0.2% sevoflurane
Drug: 0.4% Sevoflurane
Registration Number
NCT00000262
Lead Sponsor
University of Chicago
Brief Summary

The purpose of this study is to determine the effects of combined sevoflurane and nitrous oxide inhalation on mood, psychomotor performance, and the pain response in humans.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Placebo +/- 30% Nitrous oxide30% Nitrous oxide-
Placebo +/- 30% Nitrous oxidePlacebo-
Sevoflurane 0.2% +/- 30% Nitrous oxide30% Nitrous oxide-
Sevoflurane 0.2% +/- 30% Nitrous oxide0.2% sevoflurane-
Sevoflurane 0.4% +/- 30% Nitrous oxide30% Nitrous oxide-
Sevoflurane 0.4% +/- 30% Nitrous oxide0.4% Sevoflurane-
Primary Outcome Measures
NameTimeMethod
Pain intensity, pain bothersomenessDuring inhalation

Inhalation was for 68 min divided into 4 blocks with nitrous oxide added during either block 2 or block 4

MoodDuring inhalation

Inhalation was for 68 min divided into 4 blocks with nitrous oxide added during either block 2 or block 4

Psychomotor performanceDuring inhalation

Inhalation was for 68 min divided into 4 blocks with nitrous oxide added during either block 2 or block 4

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Chicago, Anesthesia & Critical Care

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath